Bapsi Chakravarthy

446 total citations
15 papers, 261 citations indexed

About

Bapsi Chakravarthy is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bapsi Chakravarthy has authored 15 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Bapsi Chakravarthy's work include Gastric Cancer Management and Outcomes (7 papers), Esophageal Cancer Research and Treatment (7 papers) and Lung Cancer Treatments and Mutations (3 papers). Bapsi Chakravarthy is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Esophageal Cancer Research and Treatment (7 papers) and Lung Cancer Treatments and Mutations (3 papers). Bapsi Chakravarthy collaborates with scholars based in United States and Canada. Bapsi Chakravarthy's co-authors include Caroline van Eck, M. E. Clark, Nancy Wells, Joseph T. Hepworth, Jordan Berlin, Dana B. Cardin, Cathy Eng, Yu Shyr, Huiyun Wu and Chan Shen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Bapsi Chakravarthy

15 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bapsi Chakravarthy United States 9 101 86 85 81 67 15 261
Pamela Hebbard Canada 9 36 0.4× 61 0.7× 84 1.0× 99 1.2× 18 0.3× 30 318
R. Buller United States 7 20 0.2× 46 0.5× 52 0.6× 35 0.4× 13 0.2× 8 350
Wenyan Yao China 11 22 0.2× 30 0.3× 43 0.5× 56 0.7× 26 0.4× 23 344
Florence Marteau France 10 13 0.1× 45 0.5× 93 1.1× 34 0.4× 44 0.7× 30 356
Christopher Gibbons United States 8 10 0.1× 62 0.7× 101 1.2× 152 1.9× 32 0.5× 12 323
Petros Kitsios Cyprus 4 17 0.2× 89 1.0× 59 0.7× 25 0.3× 11 0.2× 10 188
Jordi Craven–Bartle Spain 9 18 0.2× 86 1.0× 85 1.0× 37 0.5× 5 0.1× 25 274
Nadine R. Taghian United States 6 18 0.2× 19 0.2× 226 2.7× 105 1.3× 13 0.2× 13 379
Mathias Kvist Mejdahl Denmark 8 26 0.3× 24 0.3× 150 1.8× 167 2.1× 7 0.1× 11 347
Elan Hahn Canada 11 10 0.1× 61 0.7× 122 1.4× 100 1.2× 9 0.1× 44 274

Countries citing papers authored by Bapsi Chakravarthy

Since Specialization
Citations

This map shows the geographic impact of Bapsi Chakravarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bapsi Chakravarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bapsi Chakravarthy more than expected).

Fields of papers citing papers by Bapsi Chakravarthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bapsi Chakravarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bapsi Chakravarthy. The network helps show where Bapsi Chakravarthy may publish in the future.

Co-authorship network of co-authors of Bapsi Chakravarthy

This figure shows the co-authorship network connecting the top 25 collaborators of Bapsi Chakravarthy. A scholar is included among the top collaborators of Bapsi Chakravarthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bapsi Chakravarthy. Bapsi Chakravarthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Uboha, Nataliya V., Noah Graham, Lakshmi Rajdev, et al.. (2022). EA2183: A phase III study of consolidative radiotherapy in patients with oligometastatic HER2-negative esophageal and gastric adenocarcinoma.. Journal of Clinical Oncology. 40(16_suppl). TPS4162–TPS4162. 2 indexed citations
2.
Shen, Chan, Dana B. Cardin, Marcus Tan, et al.. (2022). Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer. Cancers. 14(2). 283–283. 27 indexed citations
3.
4.
5.
6.
Suntharalingam, Mohan, Kathryn Winter, David H. Ilson, et al.. (2014). The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.. Journal of Clinical Oncology. 32(3_suppl). LBA6–LBA6. 17 indexed citations
7.
Winter, Kathryn, David H. Ilson, Adam P. Dicker, et al.. (2014). The Initial Report of Local Control on RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Treated Without Surgery. International Journal of Radiation Oncology*Biology*Physics. 90(1). S3–S3. 9 indexed citations
8.
Ilson, David H., Jennifer Moughan, Mohan Suntharalingam, et al.. (2014). RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.. Journal of Clinical Oncology. 32(15_suppl). 4007–4007. 17 indexed citations
9.
Yang, Edward S. & Bapsi Chakravarthy. (2009). Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence. Breast Diseases A Year Book Quarterly. 20(2). 202–203. 2 indexed citations
10.
Yang, Edward & Bapsi Chakravarthy. (2009). Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma. Breast Diseases A Year Book Quarterly. 20(4). 440–441. 1 indexed citations
11.
Clark, M. E., et al.. (2006). Use of Preferred Music to Reduce Emotional Distress and Symptom Activity During Radiation Therapy. Journal of Music Therapy. 43(3). 247–265. 122 indexed citations
12.
Kim, Dong Wook, Charles D. Blanke, Huiyun Wu, et al.. (2006). Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer. International Journal of Radiation Oncology*Biology*Physics. 67(2). 397–404. 19 indexed citations
13.
Tedesco, Karen L., Jordan Berlin, Mace L. Rothenberg, et al.. (2005). A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas. Radiotherapy and Oncology. 76(1). 54–58. 8 indexed citations
14.
Tedesco, Karen L., Jordan Berlin, Charles D. Blanke, et al.. (2005). Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer. International Journal of Radiation Oncology*Biology*Physics. 61(5). 1364–1370. 1 indexed citations
15.
Chakravarthy, Bapsi. (2003). Combined modality management of breast cancer: development of predictive markers through proteomics. Seminars in Oncology. 30(4 Suppl 9). 23–36. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela Hebbard Breakdown of academic impact, for papers by R. Buller Breakdown of academic impact, for papers by Wenyan Yao Breakdown of academic impact, for papers by Florence Marteau Breakdown of academic impact, for papers by Christopher Gibbons Breakdown of academic impact, for papers by Petros Kitsios Breakdown of academic impact, for papers by Jordi Craven–Bartle Breakdown of academic impact, for papers by Nadine R. Taghian Breakdown of academic impact, for papers by Mathias Kvist Mejdahl Breakdown of academic impact, for papers by Elan Hahn
Rankless by CCL
2026